[ALR] Alere Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 40.33 Change: -0.17 (-0.42%)
Ext. hours: Change: 0 (0%)

chart ALR

Refresh chart

Description: Alere Inc. provides point-of-care diagnostics and services for cardiology, infectious disease, toxicology, and diabetes in the United States and internationally. Its Professional Diagnostics segment provides diagnostic test products and other in vitro diagnostic tests to medical professionals and laboratories for detection of diseases and conditions in the areas of cardiology, infectious diseases, toxicology, diabetes, oncology, and women?s health, as well as offers connected device technologies. The company?s Health Information Solutions segment offers integrated programs and services focused on wellness, disease and condition management, productivity enhancement, and informatics. This segment?s health improvement programs comprise patient self-testing, condition and case management, women?s and children?s health, and health and wellness programs. Its Consumer Diagnostics segment provides products for over-the-counter pregnancy and fertility/ovulation test markets; and over-the-counter drug tests for at-home

Fundamental Ratios
Shares Outstanding EPS-2.2 EPS Growth - 4 Quarters-466.28% EPS Growth - Q/Q92.35%
EPS Growth - Y/Y-37.2% Sales Growth - 4 Quarters -26.67% Sales Growth - Q/Q-8.8% P/E-22.82
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA2.88% ROE8.54% ROI3.38%
Current Ratio2.18 Quick Ratio1.61 Long Term Debt/Equity3.9 Debt Ratio0.32
Gross Margin46.69% Operating Margin3.54% Net Profit Margin6.88% Dividend Payout Ratio-12.03%
Dividend Yield
Fundamental Data
Cash From Financing Activities-566.72 M Cash From Investing Activities557.21 M Cash From Operating Activities28.38 M Gross Profit293.49 M
Net Profit209.14 M Operating Profit27.4 M Total Assets6.15 B Total Current Assets1.44 B
Total Current Liabilities661.24 M Total Debt3.13 B Total Liabilities4.08 B Total Revenue608.15 M
Technical Data
High 52 week50.99 Low 52 week34.83 Last close50.99 Last change0%
RSI Average true range3.64 Beta0.76 Volume455.09 K
Simple moving average 20 days0.41% Simple moving average 50 days1.77% Simple moving average 200 days10.29%
Performance Data
Performance Week0% Performance Month1.27% Performance Quart1.13% Performance Half3.98%
Performance Year15.62% Performance Year-to-date30.84% Volatility daily0.94% Volatility weekly2.1%
Volatility monthly4.31% Volatility yearly14.92% Relative Volume142.33% Average Volume1.51 M
New High New Low

News

2017-11-02 14:55:08 | Public health care company to layoff 182, close two South Florida offices

2017-10-19 14:23:00 | Abbott Laboratories Q3 2017 Earnings Conference Call Transcript ABT

2017-10-05 15:35:10 | Alere Inc. -- Moody's to withdraw Alere's ratings following debt redemption

2017-10-03 19:01:00 | Lifshitz & Miller LLP Announces Investigation of Alere Inc., Emergent BioSolutions, Inc., Frontier Communications Corporation, HSN, Inc., Insys Therapeutics Inc., LSB Industries, Inc. and Otonomy, Inc.

2017-10-02 16:45:08 | Abbott to Gain from Alere's Takeover Due for Oct 3 Closure

2017-10-02 16:36:49 | Abbott-Alere Deal Wins Conditional US Antitrust Approval

2017-10-02 08:01:32 | See what the IHS Markit Score report has to say about Alere Inc.

2017-10-02 07:30:00 | Corporate News Blog - Alere Announces Agreement with the US Department of Justice; Settles the Investigations Concerning Previous Foreign Acquisitions

2017-10-02 07:00:00 | Alere Receives FDA Clearance for Alere™ i Influenza A & B 2 Rapid Molecular Test

2017-09-29 13:28:17 | Alere Reaches Settlement With SEC

2017-09-29 12:12:00 | Alere Announces the U.S. Department of Justice Closes Investigation

2017-09-29 10:31:10 | Abbott Labs' Torturous Deal Saga Isn't Over Yet

2017-09-29 09:26:00 | Abbott Acquisition of Alere Set to Close on October 3, 2017

2017-09-28 21:37:00 | Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice

2017-09-28 16:45:40 | [$$] Alere Settles With SEC Over Accounting-Fraud Allegations

2017-09-28 15:04:00 | FTC Approves Abbott's Acquisition of Alere, Stock Jumps

2017-09-28 14:50:38 | Abbott wins U.S. antitrust approval to buy Alere with conditions

2017-09-28 14:20:11 | Waltham's Alere settles SEC accounting fraud charges for $13M

2017-09-28 12:42:59 | Alere to pay more than $13 million to resolve U.S. SEC probe

2017-09-28 11:50:00 | Alere Announces Settlement with SEC

2017-09-20 23:19:00 | Alere, Inc. – Value Analysis NYSE:ALR : September 21, 2017

2017-09-19 12:23:00 | Here's Why Quidel Corporation Stock Is Popping Today

2017-09-19 09:36:20 | Alere, Inc. breached its 50 day moving average in a Bullish Manner : ALR-US : September 19, 2017

2017-09-18 20:27:00 | Alere Announces Intent to Voluntarily Delist Series B Convertible Perpetual Preferred Stock from the NYSE Conditioned Upon the Completion of its Acquisition by Abbott

2017-09-18 20:22:00 | Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock

2017-09-15 22:50:00 | ALERE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alere Inc. - ALR

2017-09-11 10:06:54 | See what the IHS Markit Score report has to say about Alere Inc.

2017-09-08 22:50:00 | ALERE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alere Inc. - ALR

2017-09-08 11:11:23 | Alere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : September 8, 2017

2017-09-06 10:07:07 | See what the IHS Markit Score report has to say about Alere Inc.

2017-09-04 08:01:56 | See what the IHS Markit Score report has to say about Alere Inc.

2017-09-01 22:50:00 | ALERE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Alere Inc. - ALR

2017-09-01 08:04:50 | See what the IHS Markit Score report has to say about Alere Inc.

2017-08-31 08:10:16 | See what the IHS Markit Score report has to say about Alere Inc.

2017-08-30 08:05:10 | See what the IHS Markit Score report has to say about Alere Inc.

2017-08-28 08:11:12 | New Strong Sell Stocks for August 28th

2017-08-25 15:43:09 | ETFs with exposure to Alere, Inc. : August 25, 2017

2017-08-16 10:31:27 | Alere, Inc. :ALR-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

2017-08-16 08:02:43 | See what the IHS Markit Score report has to say about Alere Inc.

2017-08-15 08:02:59 | See what the IHS Markit Score report has to say about Alere Inc.

2017-08-12 08:02:54 | See what the IHS Markit Score report has to say about DST Systems Inc.

2017-08-11 07:00:00 | Alere Provides Notice to Holders of Series B Convertible Perpetual Preferred Stock

2017-08-04 09:54:29 | Alere, Inc. breached its 50 day moving average in a Bearish Manner : ALR-US : August 4, 2017

2017-08-03 06:41:00 | Alere Reports Second Quarter 2017 Financial Results

2017-07-31 07:00:00 | Immunalysis Receives FDA Clearance for SEFRIA™ Fentanyl Urine Drug Screening Test

2017-07-25 14:06:05 | What Were Abbott’s Key Growth Drivers for 2Q17?

2017-07-24 15:25:10 | Abbott deal will cost Alere three business units — and untold employees

2017-07-20 12:00:00 | Abbott CEO: Another Alere-Related Divestiture Coming Soon

2017-07-19 15:56:00 | Alere, St. Jude Deals in Focus as Abbott Releases Q2 Earnings

2017-07-18 17:21:00 | Quidel Diversifies With Alere's Triage Assets